Drew Amorosi

Individuals experiencing more frequent exposure to light during nighttime hours may have a higher risk for death, results from a retrospective cohort analysis published in PNAS showed.

Patients referred for percutaneous coronary intervention after acute myocardial infarction did not experience improved cardiovascular outcomes when taking colchicine compared with placebo, refuting previous study results. Healio previously reported that colchicine reduced risk for cardiovascular death, resuscitated cardiac arrest, MI, stroke or hospitalization for angina in the COLCOT trial of

Sotagliflozin was not recommended for approval by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee for glucose control as an adjunct to insulin in adults with type 1 diabetes and chronic kidney disease.

Researchers found that women with type 2 diabetes who received at least two doses of GLP-1 receptor agonists had a 27% lower risk for developing new-onset uterine fibroids compared to those who use metformin or insulin.

Key takeaways: Vitamin K markedly reduced the mean weekly frequency of nocturnal leg cramps in the intervention group.

Epinephrine autoinjectors may have limited effectiveness in helping patients survive anaphylaxis events, according to a review published in Clinical and Experimental Allergy

In part one of a three-part Healio exclusive series, experts discussed the need for clinical guidance and evidence for the use of AI to improve cardiovascular outcomes.

An analysis of STI screening for gonorrhea, chlamydia and syphilis at 11 EDs revealed that less than 3% of patients tested for one of the three STIs were also tested for HIV, despite the CDC's recommendation for HIV co-testing.

A pilot study revealed that patients treated with the antipsychotic olanzapine plus an intestinal microsomal triglyceride transfer protein inhibitor

WISDOM, a research study comparing annual mammography with a personalized approach to screening based on individual risk factors, is currently